Some 42% of patients attending a dedicated diabetes clinic have signs of established chronic kidney disease, the first detailed research of its kind in Ireland has revealed.
Jun 14, 2021
0
5
According to a seven year study led by researchers at Queen Mary University of London, involving more than 3 million people, only 8% of those at greater risk of heart disease who would benefit from taking statins, were prescribed ...
Jun 14, 2021
0
1
According to the Global Burden of Disease Study 2017, close to nine percent of the global population lives with some form of chronic kidney disease, or CKD. Not only does the condition affect renal function, but CKD has long ...
Jun 4, 2021
0
13
Chronic kidney disease (CKD) is caused by diabetes and hypertension. In 2017, the global prevalence of CKD was 9.1 percent, which is approximately 700 million cases. Chronic kidney damage is assessed by scoring the amount ...
May 24, 2021
0
6
Patients with chronic kidney disease and Type 2 diabetes who took the experimental drug finerenone were about 30% less likely to develop the heart rhythm disorder atrial fibrillation (AFib) than those taking a placebo, according ...
May 17, 2021
0
2
Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not significantly reduce the risk of organ failure or death or improve recovery in patients hospitalized with COVID-19 who are at high risk of developing ...
May 17, 2021
0
3
Many parents of children with chronic illnesses felt hospitals were unsafe during the COVID-19 pandemic and took to social media to find information relevant to them, a Southampton-led study suggests.
May 12, 2021
0
5
Chronic kidney disease affects the lives of millions of people. It's a condition marked by the loss of several key kidney functions such as removing toxins from the blood. To compensate for this loss, a patient can undergo ...
May 12, 2021
0
3
Chronic kidney disease is when a person's kidneys progressively lose their ability to filter waste from the blood and eliminate fluids. Now a new study has found that people with reduced kidney function may have an increased ...
May 5, 2021
0
32
(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.
May 4, 2021
0
9
